Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial ; volume:15 ; number:1 ; day:9 ; month:8 ; year:2014 ; pages:1-6 ; date:12.2014
Trials ; 15, Heft 1 (9.8.2014), 1-6, 12.2014
- Urheber
-
Olofsson, Roger
- Beteiligte Personen und Organisationen
-
Ny, Lars
Eilard, Malin Sternby
Rizell, Magnus
Cahlin, Christian
Stierner, Ulrika
Lönn, Ulf
Hansson, Johan
Ljuslinder, Ingrid
Lundgren, Lotta
Ullenhag, Gustav
Kiilgaard, Jens Folke
Nilsson, Jonas
Lindnér, Per
SpringerLink (Online service)
- DOI
-
10.1186/1745-6215-15-317
- URN
-
urn:nbn:de:1111-2016050235061
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Olofsson, Roger
- Ny, Lars
- Eilard, Malin Sternby
- Rizell, Magnus
- Cahlin, Christian
- Stierner, Ulrika
- Lönn, Ulf
- Hansson, Johan
- Ljuslinder, Ingrid
- Lundgren, Lotta
- Ullenhag, Gustav
- Kiilgaard, Jens Folke
- Nilsson, Jonas
- Lindnér, Per
- SpringerLink (Online service)
Ähnliche Objekte (12)
Erratum to: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
Scandium
Scandium
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial
Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial
Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver (RETNET): study protocol for a randomized controlled trial
A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma
Detection of metastases using circulating tumour DNA in uveal melanoma
Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?
Scandium Triflate
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases
Erratum to: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
Scandium
Scandium
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial
Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial
Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver (RETNET): study protocol for a randomized controlled trial
A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma
Detection of metastases using circulating tumour DNA in uveal melanoma
Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?
Scandium Triflate
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases
Erratum to: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
Scandium
Scandium
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial
Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial
Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver (RETNET): study protocol for a randomized controlled trial
A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma
Detection of metastases using circulating tumour DNA in uveal melanoma
Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?
Scandium Triflate